Envestnet Portfolio Solutions
BSX icon

Envestnet Portfolio Solutions’s Boston Scientific BSX Stock Holding History

Envestnet Portfolio Solutions’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.12M Sell
96,782
-8,791
-8% -$477K 0.02% 366
2026
Q1 		$6.62M Buy
105,573
+8,418
+9% +$673K 0.04% 243
2025
Q4 		$9.26M Buy
97,155
+30,469
+46% +$2.99M 0.03% 254
2025
Q3 		$6.51M Buy
66,686
+730
+1% +$75.6K 0.02% 298
2025
Q2 		$7.08M Sell
65,956
-901
-1% -$91.2K 0.03% 279
2025
Q1 		$6.74M Buy
66,857
+6,551
+11% +$660K 0.03% 298
2024
Q4 		$5.39M Sell
60,306
-5,029
-8% -$443K 0.02% 376
2024
Q3 		$5.48M Sell
65,335
-1,784
-3% -$141K 0.02% 370
2024
Q2 		$5.17M Sell
67,119
-8,759
-12% -$641K 0.02% 362
2024
Q1 		$5.2M Buy
75,878
+5,305
+8% +$341K 0.02% 364
2023
Q4 		$4.08M Sell
70,573
-7,057
-9% -$377K 0.02% 387
2023
Q3 		$4.1M Buy
+77,630
New +$4.07M 0.02% 361

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Envestnet Portfolio Solutions's BSX Position: Q2 2026 in Review

Envestnet Portfolio Solutions reduced its Boston Scientific (BSX) stake by 8.3% in Q2 2026, selling an estimated $477K and leaving 96,782 shares worth $4.12M. The position accounts for 0.02% of the portfolio, ranked #366.

Envestnet Portfolio Solutions first reported a position in BSX in Q3 2023 and has held it in 12 quarters since. The position peaked at $9.26M in Q4 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Envestnet Portfolio Solutions held 96,782 shares of Boston Scientific worth $4.12M as of Q2 2026.
  • Envestnet Portfolio Solutions sold 8,791 Boston Scientific shares in Q2 2026, an estimated $477K.
  • Boston Scientific made up 0.02% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #366 holding.
  • Envestnet Portfolio Solutions first reported a position in Boston Scientific in Q3 2023 and has held it in 12 quarters since.
  • Envestnet Portfolio Solutions's Boston Scientific position peaked at $9.26M in Q4 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.